More than one-third of prostate cancer diagnoses manifest as a slow-growing, harm-unlikely form. Still, for that other two-thirds, researchers at the U-M Rogel Cancer Center developed a new test for prostate cancer that isolates the more aggressive form that needs immediate treatment. Learn more about the process of the test’s development in this article from the Institute for Healthcare Policy and Innovation.
